Post-transplantation lymphoproliferative disorder.
Schooler
Vincent C
VC
Division of Gastroenterology and Hepatology, University of Alabama at Birmingham, Birmingham, AL, USA.
Ragland
Brian
B
Lazenby
Audrey
A
Eloubeidi
Mohamad A
MA
D001706:Biopsy; D003586:Cytomegalovirus Infections / Q000175:diagnosis / Q000473:pathology; D003680:Deglutition Disorders / Q000209:etiology* / Q000473:pathology; D004359:Drug Therapy, Combination; D020031:Epstein-Barr Virus Infections / Q000175:diagnosis* / Q000473:pathology; D004935:Esophageal Diseases / Q000175:diagnosis* / Q000473:pathology; D004945:Esophagoscopy; D004947:Esophagus / Q000473:pathology; D005260:Female; D016027:Heart Transplantation; D006801:Humans; D007013:Hypopharynx / Q000473:pathology; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects; D016030:Kidney Transplantation; D008232:Lymphoproliferative Disorders / Q000175:diagnosis* / Q000473:pathology; D008875:Middle Aged; D009181:Mycoses / Q000175:diagnosis / Q000473:pathology; D010608:Pharyngeal Diseases / Q000175:diagnosis* / Q000473:pathology; D011183:Postoperative Complications / Q000209:etiology* / Q000473:pathology; D011706:Pyloric Antrum / Q000473:pathology; D013276:Stomach Ulcer / Q000175:diagnosis* / Q000473:pathology; D014456:Ulcer / Q000175:diagnosis* / Q000473:pathology
D007166:Immunosuppressive Agents